Literature DB >> 11878807

A continuous fluorimetric assay for tumor necrosis factor-alpha converting enzyme.

Guixian Jin1, Xinyi Huang, Roy Black, Martin Wolfson, Charles Rauch, Herbert McGregor, George Ellestad, Rebecca Cowling.   

Abstract

Fluorogenic peptide substrates with fluorophore/quencher-capped ends have found extensive use in monitoring protease activity in the screening of small-molecule libraries for protease inhibitors. We report here the identification and characterization of a fluorogenic substrate for tumor necrosis factor-alpha converting enzyme (TACE). This substrate is a 10-amino-acid peptide (LAQAVRSSSR) capped with an o-aminobenzoyl group on the N-terminal end and with a 3-(2,4-dinitrophenyl)-L-2,3-diaminopropionic amide group on the C-terminal end. Exhaustive enzymatic conversion of the substrate to products resulted in a fluorescence enhancement of -11-fold. A single cleavage occurred at the A-V scissile bond of the peptide. The validity of this fluorimetric assay for TACE was corroborated by an independent HPLC method. Interestingly, the hydrolysis of the substrate displayed positive cooperativity with a Hill coefficient of 1.5, while the hydrolysis of the corresponding uncapped peptide displayed Michaelis-Menten kinetics. A k(cat) value of 21.6 s(-1) and an S(0.5) value of 342 microM were obtained for the fluorogenic substrate. The addition of the two capping groups on the two ends of the peptide enhanced the k(cat) value by 64-fold. Nine additional decapeptides that contained the same capping groups on the two ends and substitutions at the P1 and P1' sites were also tested. TACE appears to slightly prefer the A-V scissile bond. The enzyme also cleaves scissile bonds such as F-V, A-I, and A-L efficiently. (C)2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11878807     DOI: 10.1006/abio.2001.5549

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  19 in total

1.  Hypothalamic tumor necrosis factor-alpha converting enzyme mediates excitatory amino acid-dependent neuron-to-glia signaling in the neuroendocrine brain.

Authors:  Alejandro Lomniczi; Anda Cornea; Maria E Costa; Sergio R Ojeda
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

2.  Anthranilate derivatives as TACE inhibitors: docking based CoMFA and CoMSIA analyses.

Authors:  Malkeet Singh Bahia; Shravan Kumar Gunda; Shwetha Reddy Gade; Saikh Mahmood; Ravikumar Muttineni; Om Silakari
Journal:  J Mol Model       Date:  2010-03-28       Impact factor: 1.810

3.  Cyclic stretch stimulates vascular smooth muscle cell alignment by redox-dependent activation of Notch3.

Authors:  Jian-Hong Zhu; Chun-Lin Chen; Sheila Flavahan; Jennifer Harr; Baogen Su; Nicholas A Flavahan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-17       Impact factor: 4.733

4.  The waved with open eyelids (woe) locus is a hypomorphic mouse mutation in Adam17.

Authors:  E L Hassemer; S M Le Gall; R Liegel; M McNally; B Chang; C J Zeiss; R D Dubielzig; K Horiuchi; T Kimura; Y Okada; C P Blobel; D J Sidjanin
Journal:  Genetics       Date:  2010-03-01       Impact factor: 4.562

5.  Activation of endothelial intrinsic NF-{kappa}B pathway impairs protein C anticoagulation mechanism and promotes coagulation in endotoxemic mice.

Authors:  Dongmei Song; Xiaobing Ye; Honglei Xu; Shu Fang Liu
Journal:  Blood       Date:  2009-07-20       Impact factor: 22.113

6.  Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10.

Authors:  Cristina I Caescu; Grace R Jeschke; Benjamin E Turk
Journal:  Biochem J       Date:  2009-10-23       Impact factor: 3.857

7.  Reduction of beta-amyloid levels by novel protein kinase C(epsilon) activators.

Authors:  Thomas J Nelson; Changhai Cui; Yuan Luo; Daniel L Alkon
Journal:  J Biol Chem       Date:  2009-10-22       Impact factor: 5.157

8.  Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study.

Authors:  Devjit Tripathy; Giuseppe Daniele; Teresa V Fiorentino; Zandra Perez-Cadena; Alberto Chavez-Velasquez; Subhash Kamath; Paolo Fanti; Christopher Jenkinson; Francesco Andreozzi; Massimo Federici; Amalia Gastaldelli; Ralph A Defronzo; Franco Folli
Journal:  Diabetologia       Date:  2013-06-30       Impact factor: 10.122

9.  Metalloproteinase- and gamma-secretase-mediated cleavage of protein-tyrosine phosphatase receptor type Z.

Authors:  Jeremy Pak Hong Chow; Akihiro Fujikawa; Hidetada Shimizu; Ryoko Suzuki; Masaharu Noda
Journal:  J Biol Chem       Date:  2008-08-18       Impact factor: 5.157

10.  Aldose reductase regulates high glucose-induced ectodomain shedding of tumor necrosis factor (TNF)-alpha via protein kinase C-delta and TNF-alpha converting enzyme in vascular smooth muscle cells.

Authors:  Aramati B M Reddy; Kota V Ramana; Sanjay Srivastava; Aruni Bhatnagar; Satish K Srivastava
Journal:  Endocrinology       Date:  2008-09-04       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.